SEARCH

SEARCH BY CITATION

References

  • Bader M, Peters J, Baltatu O, Muller DN, Luft FC & Ganten D (2001). Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79, 76102.
  • Baltatu O, Lippoldt A, Hansson A, Ganten D & Bader M (1998). Local renin-angiotensin system in the pineal gland. Brain Res Mol Brain Res 54, 237242.
  • Burcklé CA, Jan Danser AH, Müller DN, Garrelds IM, Gasc JM, Popova E, Plehm R, Peters J, Bader M & Nguyen G (2006). Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 47, 552556.
  • Danser A, Batenburg W & Van Esch J (2007). Prorenin and the (pro)renin receptor—an update. Nephrol Dial Transplant 22, 12881292.
  • De Gasparo M, Catt KJ, Inagami T, Wright JW & Unger T (2000). International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52, 415472.
  • Dzau VJ, Ingelfinger J, Pratt RE & Ellison KE (1986). Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension 8, 544548.
  • Hermann K, Phillips MI, Hilgenfeldt U & Raizada MK (1988). Biosynthesis of angiotensinogen and angiotensins by brain cells in primary culture. J Neurochem 51, 398405.
  • Huang XC, Richards EM & Sumners C (1996). Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J Biol Chem 271, 1563515641.
  • Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA & Border W (2006). Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 69, 105113.
  • Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AH, Ishida Y, Inagami T & Saruta T (2004). Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin. J Clin Invest 114, 11281135.
  • Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M & Itoh H (2007). The (pro)renin receptor and the kidney. Semin Nephrol 27, 524528.
  • Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, Nishiyama A, Inagami T & Hayashi M (2006). Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47, 894900.
  • Kobori H, Nangaku M, Navar LG & Nishiyama A (2007). The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59, 251287.
  • Lippoldt A, Fuxe K & Luft FC (2001). A view of renin in the brain. J Mol Med 79, 7173.
  • McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA & Chai SY (2003). The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35, 901918.
  • Morimoto S & Sigmund CD (2002). Angiotensin mutant mice: a focus on the brain renin-angiotensin system. Neuropeptides 36, 194200.
  • Nguyen G (2007). The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology. Curr Opin Nephrol Hypertens 16, 129133.
  • Nguyen G, Delarue F, Burcklâe C, Bouzhir L, Giller T & Sraer JD (2002). Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109, 14171427.
  • Osborn JW, Fink GD, Sved AF, Toney GM & Raizada MK (2007). Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9, 228235.
  • Peterson JR, Sharma RV & Davisson RL (2006). Reactive oxygen species in the neuropathogenesis of hypertension. Curr Hypertens Rep 8, 232241.
  • Phillips MI & Sumners C (1998). Angiotensin II in central nervous system physiology. Regul Pept 78, 111.
  • Raizada MK, Lu D & Sumners C (1995). AT1 receptors and angiotensin actions in the brain and neuronal cultures of normotensive and hypertensive rats. Adv Exp Med Biol 377, 331348.
  • Sakai K & Sigmund CD (2005). Molecular evidence of tissue renin-angiotensin systems: a focus on the brain. Curr Hypertens Rep 7, 135140.
  • Satofuka S, Ichihara A, Nagai N, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Itoh H, Oike Y & Ishida S (2007). Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci 48, 422429.
  • Sellers KW, Sun C, Diez-Freire C, Waki H, Morisseau C, Falck JR, Hammock BD, Paton JF & Raizada MK (2005). Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat. FASEB J 19, 626628.
  • Sumners C, Tang W, Zelezna B & Raizada MK (1991). Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proc Natl Acad Sci USA 88, 75677571.
  • Sun C, Du J, Sumners C & Raizada MK (2003). PI3-kinase inhibitors abolish the enhanced chronotropic effects of angiotensin II in spontaneously hypertensive rat brain neurons. J Neurophysiol 90, 31553160.
  • Sun C, Sellers KW, Sumners C & Raizada MK (2005). NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ Res 96, 659666.
  • Suzuki F, Hayakawa M, Nakagawa T, Nasir UM, Ebihara A, Iwasawa A, Ishida Y, Nakamura Y & Murakami K (2003). Human prorenin has “gate and handle” regions for its non-proteolytic activation. J Biol Chem 278, 2221722222.
  • Veerasingham SJ & Raizada MK (2003). Brain reninangiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 139, 191202.
  • Veerasingham SJ, Yamazato M, Berecek KH, Wyss JM & Raizada MK (2005). Increased PI3-kinase in presympathetic brain areas of the spontaneously hypertensive rat. Circ Res 96, 277279.
  • Yamazato M, Yamazato Y, Sun C, Diez-Freire C & Raizada MK (2007). Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 49, 926931.
  • Yang H, Lu D, Yu K & Raizada MK (1996). Regulation of neuromodulatory actions of angiotensin II in the brain neurons by the Ras-dependent mitogen-activated protein kinase pathway. J Neurosci 16, 40474058.
  • Zhu M, Sumners C, Gelband CH & Posner P (2001). Chronotropic effect of angiotensin II via type 2 receptors in rat brain neurons. J Neurophysiol 85, 21772183.